AGP
LRMR icon

Artia Global Partners’s Larimar Therapeutics LRMR Stock Holding History

Artia Global Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-90,490
Closed -$593K – 50
2024
Q3 		$593K Hold
90,490
– – 0.16% 41
2024
Q2 		$656K Buy
90,490
+32,300
+56% +$247K 0.13% 42
2024
Q1 		$442K Buy
+58,190
New +$453K 0.09% 45
2023
Q2 		– Sell
-38,057
Closed -$172K – 40
2023
Q1 		$172K Buy
+38,057
New +$199K 0.06% 36

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Artia Global Partners's LRMR Position: Q4 2024 in Review

Artia Global Partners sold out of Larimar Therapeutics (LRMR) in Q4 2024, closing a stake of 90,490 shares — an estimated $593K sold.

Artia Global Partners first reported a position in LRMR in Q1 2023 and held it in 4 quarters. The position peaked at $656K in Q2 2024. 116 funds tracked by Wall St. Rank hold LRMR as of Q4 2024.

  • Artia Global Partners reported no remaining Larimar Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Artia Global Partners sold 90,490 Larimar Therapeutics shares in Q4 2024, an estimated $593K.
  • Artia Global Partners first reported a position in Larimar Therapeutics in Q1 2023 and held it in 4 quarters.
  • Artia Global Partners's Larimar Therapeutics position peaked at $656K in Q2 2024.
  • 116 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2024.

Based on Artia Global Partners's 13F filing for Q4 2024, filed 14 Feb 2025.